ArticleOncology letters2019
Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell lines.
Hui-Li Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleOncology letters2019
Hui-Li Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.